Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Guidelines on CVD prevention: confusing or complementary?

De Backer G, Catapano AL, Chapman J, Graham I, Reiner Z, Perk J, Wiklund O.

Atherosclerosis. 2013 Jan;226(1):299-300. doi: 10.1016/j.atherosclerosis.2012.10.042. Epub 2012 Oct 17. No abstract available.

PMID:
23102598
2.

Guidelines on CVD prevention: confusing or complementary?

De Backer G, Catapano AL, Chapman J, Graham I, Reiner Z, Perk J, Wiklund O.

Eur J Prev Cardiol. 2013 Feb;20(1):6-8. doi: 10.1177/2047487312464001. No abstract available.

PMID:
23258929
3.

Polish forum for prevention guidelines on cardiovascular diseases prevention in women.

Kornacewicz-Jach Z, Podolec P, Kopeć G, Pajak A, Zdrojewski T, Naruszewicz M, Stańczyk J, Undas A, Kozek E, Tykarski A, Opala G, Windak A, Torbicki A, Musiał J.

Kardiol Pol. 2007 Mar;65(3):334-7. English, Polish. No abstract available.

PMID:
17615665
4.

Polish Forum for Prevention of Cardiovascular Diseases Guidelines on prophylactic pharmacotherapy.

Podolec P, Kopeć G, Undas A, Pająk A, Godycki-Ćwirko M, Zdrojewski T, Jankowski P, Drygas W, Rynkiewicz A, Piotrowicz R, Czarnecka D, Naruszewicz M, Opala G, Stańczyk J, Kozek E, Windak A, Banasiak W, Guzik T; Polish Forum for Prevention of Cardiovascular Diseases Task Force on Guidelines.

Kardiol Pol. 2011;69(2):195-7. No abstract available.

5.

The next steps in developing clinical practice guidelines for prevention.

Gibbons GH, Harold JG, Jessup M, Robertson RM, Oetgen WJ.

Circulation. 2013 Oct 8;128(15):1716-7. doi: 10.1161/CIRCULATIONAHA.113.005548. Epub 2013 Aug 8. No abstract available.

6.

Joint societies CVD Prevention Guidelines launched in May 2012.

Taylor J.

Eur Heart J. 2012 Jul;33(13):1539. doi: 10.1093/eurheartj/ehs137.

PMID:
22753005
7.

Guidelines for prevention of CVD in women.

Watson K.

J Fam Pract. 2005 Jul;Suppl:7-8. Review. No abstract available.

PMID:
16134559
8.

CVD prevention in women: a practice update.

Campos-Outcalt D.

J Fam Pract. 2011 Jul;60(7):421-5. Review.

PMID:
21731920
9.
10.

Benchmarking progress in the implementation of the Fourth Joint Societies' Task Force Guidelines on the Prevention of Cardiovascular Disease in Clinical Practice.

Morgan K, Burke H, McGee H.

Eur J Prev Cardiol. 2013 Feb;20(1):54-60. doi: 10.1177/2047487311433858. Epub 2012 Jan 4.

PMID:
22345672
11.

Barriers to effective implementation of guideline recommendations.

Erhardt LR.

Am J Med. 2005 Dec;118 Suppl 12A:36-41.

PMID:
16356806
12.

US heart doctors defend new prevention guidelines.

McCarthy M.

BMJ. 2013 Nov 20;347:f6957. doi: 10.1136/bmj.f6957. No abstract available.

PMID:
24259332
13.

Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study.

Dallongeville J, Banegas JR, Tubach F, Guallar E, Borghi C, De Backer G, Halcox JP, Massó-González EL, Perk J, Sazova O, Steg PG, Artalejo FR; EURIKA Investigators.

Eur J Prev Cardiol. 2012 Jun;19(3):541-50. doi: 10.1177/1741826711407705. Epub 2011 Apr 18.

PMID:
21502280
14.
15.

Prevention of cardiovascular diseases in perimenopausal women and the influence of hormone replacement therapy: an evidence-based guideline.

Gebara OC, Fernandes C, Bertolami MC.

Arq Bras Cardiol. 2009 Nov;93(5):e86-8. No abstract available.

16.

When is the use of aspirin for CVD prevention in women appropriate?

Manson JE, Bassuk SS.

Menopause. 2014 Jan;21(1):103-5. doi: 10.1097/GME.0b013e318298d74e.

PMID:
23695505
17.

National study of physician awareness and adherence to cardiovascular disease prevention guidelines.

Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, Fabunmi RP, Kwan J, Mills T, Simpson SL.

Circulation. 2005 Feb 1;111(4):499-510.

18.

Development of the Champlain primary care cardiovascular disease prevention and management guideline: tailoring evidence to community practice.

Montoya L, Liddy C, Hogg W, Papadakis S, Dojeiji L, Russell G, Akbari A, Pipe A, Higginson L.

Can Fam Physician. 2011 Jun;57(6):e202-7.

19.

A health-economic evaluation of aspirin: primary prevention and cardiovascular disease.

Sakai T, Saku K.

Intern Med. 2007;46(8):431-3. Epub 2007 Apr 17. No abstract available.

20.

Cardiometabolic risk assessment: an approach to the prevention of cardiovascular disease and diabetes mellitus.

Vasudevan AR, Ballantyne CM.

Clin Cornerstone. 2005;7(2-3):7-16. Review.

PMID:
16473256

Supplemental Content

Support Center